JLPC(SH:600513)2021-08-24 16:00Financial Performance - The company's operating revenue for the first half of 2021 reached ¥759.11 million, representing a 23.25% increase compared to ¥615.90 million in the same period last year[17]. - The net profit attributable to shareholders was ¥54.39 million, up 20.59% from ¥45.10 million in the previous year[17]. - The net profit after deducting non-recurring gains and losses was ¥51.04 million, reflecting a 14.65% increase from ¥44.52 million year-on-year[17]. - Basic earnings per share increased to ¥0.19, up 18.75% from ¥0.16 in the same period last year[18]. - The company achieved a revenue of 759.11 million yuan in the first half of 2021, representing a growth of 23.25% compared to the same period last year[39]. - The net profit attributable to shareholders reached 54.39 million yuan, an increase of 20.59% year-on-year[39]. - The company reported a total of 132.894 million RMB in actual related party transactions for the first half of 2021, compared to an estimated 601.7 million RMB[89]. - The company reported a total comprehensive income for the current period amounted to 65,286,445.06, with a significant contribution from the parent company[122]. Cash Flow and Investments - The net cash flow from operating activities decreased by 58.14% to ¥21.87 million, down from ¥52.25 million in the same period last year[17]. - The company’s cash flow from financing activities increased significantly by 118.01% to ¥73,626,970.80, reflecting an increase in short-term borrowings[44]. - Cash received from sales of goods and services was CNY 800,096,022.92, an increase of 14.4% from CNY 699,301,658.61 in the same period last year[117]. - Cash outflow from investing activities totaled CNY 170,824,054.98, up 34.1% from CNY 127,335,849.68 in the previous year[118]. - The ending cash and cash equivalents balance was CNY 153,883,081.78, down 34.5% from CNY 235,414,611.64 at the end of the first half of 2020[118]. Assets and Liabilities - The total assets of the company increased by 5.77% to ¥2.17 billion, compared to ¥2.05 billion at the end of the previous year[17]. - Total liabilities reached RMB 952,072,702.10, up from RMB 867,053,818.55, reflecting an increase of around 9.8%[106]. - The company's equity increased to RMB 1,215,321,292.45 from RMB 1,182,012,435.93, representing a growth of approximately 2.8%[106]. - The company's total assets as of June 30, 2021, amounted to ¥1,747,541,769.09, compared to ¥1,600,476,582.17 at the end of 2020, reflecting a growth of 9.2%[109]. - The company's total liabilities reached ¥773,403,363.32, up from ¥640,765,744.42 at the end of 2020, indicating a rise of 20.6%[109]. Research and Development - The company has successfully developed and launched 2 national class I new drugs, 6 class II new drugs, and 2 class III new drugs, highlighting its strong R&D capabilities[34]. - Research and development expenses rose by 26.09% to ¥23,801,633.09, indicating increased investment in R&D projects[44]. - Research and development expenses for the first half of 2021 were ¥23,801,633.09, an increase of 25.5% compared to ¥18,876,220.36 in the first half of 2020[111]. Market and Sales Strategy - The company operates in the pharmaceutical manufacturing industry, focusing on the research, production, and sales of chemical drugs, including various series such as urological drugs and cardiovascular drugs[21]. - The sales strategy includes specialized academic promotion and agency distribution, with a focus on expanding clinical coverage for key products[27]. - The company is focusing on expanding its e-commerce market presence by analyzing market rules and selecting suitable products for promotion[32]. - The company aims to improve service quality and reduce marketing expense settlement cycles to support sales growth[31]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities, indicating regulatory scrutiny[62]. - The company reported a total of 1.786164 tons of chemical oxygen demand and 0.002922 tons of total phosphorus emissions, both within the regulatory limits[65]. - The company has implemented emergency response plans for environmental incidents, with no incidents reported in the current period[69]. - The company achieved a 100% compliance rate for environmental hazard rectification by June 2021, with no environmental accidents reported in the first half of 2021[72]. Corporate Governance - The company committed to not engaging in competitive business activities that could harm its interests or those of its minority shareholders following a major asset restructuring[85]. - The company has guaranteed the independence of its management and financial systems, ensuring no interference from its controlling shareholder[86]. - The management team is experienced and proactive, ensuring timely adjustments to strategies based on industry trends and market demands[35]. Accounting Policies - The company has established specific accounting policies and estimates based on its operational characteristics[143]. - The company adheres to accounting standards, ensuring that financial statements accurately reflect its financial position and performance[144]. - The company uses RMB as its functional currency for accounting purposes[147].